Modern Rheumatology
Published by Oxford University Press (Journal Finder)
ISSN : 1439-7595 eISSN : 1439-7609
Abbreviation : Mod. Rheumatol.
Aims & Scope
Modern Rheumatology publishes original papers in English on research pertinent to rheumatology and associated areas such as pathology, physiology, clinical immunology, microbiology, biochemistry, experimental animal models, pharmacology, and orthopedic surgery.
Occasional reviews of topics which may be of wide interest to the readership will be accepted.
In addition, concise papers of special scientific importance that represent definitive and original studies will be considered.
Letters should be limited to commentaries on previous articles published in Modern Rheumatology , subjects related to rheumatology, or topics of potential interest to members of the Japan College of Rheumatology.
Rapid Communications should be very short reports of research findings, with no abstract.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 1.9 |
| 2024 | 1.80 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.821 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q2 |
h-index
| Year | Value |
|---|---|
| 2024 | 71 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 6549 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 1178 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Preservation url
- Apc url
- License
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
Citation: 1313
Authors: Hisanori, Kazuichi, Yasufumi, Mitsuhiro, Motohisa, Takako, Shoko, Tadashi, Shigeo, Shigeyuki, Hideaki, Terumi, Toru, Akira, Seiji, Tetsuhide, Kenji, Takayuki, Yoshiya, Tsuneyo, Tsutomu, Michiaki, Toshifumi, Hirohito, Kazuo, Hirotaka
-
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details
Citation: 594
Authors: Hisanori, Kazuichi, Yasufumi, Mitsuhiro, Motohisa, Takako, Shoko, Takayuki, Tsuneyo, Yoshiya, Kazuo, Tadashi, Shigeyuki, Ritsuro, Tsutomu, Naohisa, Nozomu, Yasuhito, Atsushi, Masaru, Shigeo, Dai
-
The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD
Citation: 441
Authors: Hisanori, Kazuichi, Shigeyuki, Hiroki, Hiroshi, Shoko, Nobukazu, Takashi, Yasuharu, Mitsuhiro
-
Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients
Citation: 340
Authors: Baodong, Ning, Qingqin, Tingting, Min, Haitao, Zhide, Yan, Zaixing, Renqian
-
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
Citation: 324
Authors: Hisanori, Kazuichi, Yasufumi, Mitsuhiro, Motohisa, Takako, Shoko, Tadashi, Shigeo, Shigeyuki, Hideaki, Terumi, Toru, Akira, Seiji, Tetsuhide, Kenji, Takayuki, Yoshiya, Tsuneyo, Tsutomu, Michiaki, Toshifumi, Hirohito, Kazuo, Hirotaka
-
Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
Citation: 252
Authors: Norihiro, Nobuyuki, Kazuhiko, Shinichi, Tsutomu, Junichi, Tadamitsu
-
A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease
Citation: 233
Authors: Motohisa, Hiroki, Mikiko, Chisako, Yasuyoshi, Hiroyuki, Yasuhisa, Kohzoh
-
Revised Japanese criteria for Sjögren’s syndrome (1999): availability and validity
Citation: 225
Authors: Takashi, Susumu, Nobuyuki, Yoshio, Kazuo
-
Risk of malignancies in IgG4-related disease
Citation: 223
Authors: Motohisa, Hiroki, Tetsuya, Chisako, Yasuyoshi, Keisuke, Hidetaka, Yui, Mikiko, Hiroyuki, Tetsuo, Kohzoh, Yasuhisa